These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 29334999

  • 21. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
    Hou KZ, Fu ZQ, Gong H.
    World J Gastroenterol; 2015 Jan 14; 21(2):475-83. PubMed ID: 25593462
    [Abstract] [Full Text] [Related]

  • 22. Plasma glutamate carboxypeptidase is a negative regulator in liver cancer metastasis.
    Lee JH, Cho HS, Lee JJ, Jun SY, Ahn JH, Min JS, Yoon JY, Choi MH, Jeon SJ, Lim JH, Jung CR, Kim DS, Kim HT, Factor VM, Lee YH, Thorgeirsson SS, Kim CH, Kim NS.
    Oncotarget; 2016 Nov 29; 7(48):79774-79786. PubMed ID: 27806330
    [Abstract] [Full Text] [Related]

  • 23. Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy.
    Yang Z, Zhao T, Liu H, Zhang L.
    Sci Rep; 2016 Jan 19; 6():19383. PubMed ID: 26783250
    [Abstract] [Full Text] [Related]

  • 24. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
    Lu HY, Chu HX, Tan YX, Qin XC, Liu MY, Li JD, Ren TS, Zhang YS, Zhao QC.
    Life Sci; 2020 Mar 01; 244():117343. PubMed ID: 31978449
    [Abstract] [Full Text] [Related]

  • 25. Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma.
    Yang Y, Zhang N, Zhu J, Hong XT, Liu H, Ou YR, Su F, Wang R, Li YM, Wu Q.
    Int J Oncol; 2017 Jun 01; 50(6):1977-1988. PubMed ID: 28498415
    [Abstract] [Full Text] [Related]

  • 26. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma via AMPK-FOXO1-ULK1 signaling axis-mediated autophagy.
    Xiao Q, Liu H, Wang HS, Cao MT, Meng XJ, Xiang YL, Zhang YQ, Shu F, Zhang QG, Shan H, Jiang GM.
    Theranostics; 2020 Jun 01; 10(22):10245-10261. PubMed ID: 32929346
    [Abstract] [Full Text] [Related]

  • 27. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling.
    Zhang N, Wang L, Chai ZT, Zhu ZM, Zhu XD, Ma DN, Zhang QB, Zhao YM, Wang M, Ao JY, Ren ZG, Gao DM, Sun HC, Tang ZY.
    PLoS One; 2014 Jun 01; 9(12):e115949. PubMed ID: 25542041
    [Abstract] [Full Text] [Related]

  • 28. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma.
    Ye Y, Long X, Zhang L, Chen J, Liu P, Li H, Wei F, Yu W, Ren X, Yu J.
    Oncotarget; 2016 Oct 25; 7(43):70303-70322. PubMed ID: 27611941
    [Abstract] [Full Text] [Related]

  • 29. Daucosterol Inhibits the Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells via Wnt/β-Catenin Signaling.
    Zeng J, Liu X, Li X, Zheng Y, Liu B, Xiao Y.
    Molecules; 2017 Jun 02; 22(6):. PubMed ID: 28574485
    [Abstract] [Full Text] [Related]

  • 30. The significance of EphA2-regulated Wnt/β-catenin signal pathway in promoting the metastasis of HBV-related hepatocellular carcinoma.
    Wang Y, Zhang Z, Zhu Z, Wang P, Zhang J, Liu H, Li J.
    Mol Biol Rep; 2023 Jan 02; 50(1):565-575. PubMed ID: 36350420
    [Abstract] [Full Text] [Related]

  • 31. Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.
    Bian W, Zhang H, Tang M, Zhang S, Wang L, Liu L, Wang W.
    Cell Physiol Biochem; 2018 Jan 02; 51(5):2065-2072. PubMed ID: 30522116
    [Abstract] [Full Text] [Related]

  • 32. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang M, Li SN, Anjum KM, Gui LX, Zhu SS, Liu J, Chen JK, Liu QF, Ye GD, Wang WJ, Wu JF, Cai WY, Sun GB, Liu YJ, Liu RF, Zhang ZM, Li BA.
    J Cell Sci; 2013 Dec 15; 126(Pt 24):5692-703. PubMed ID: 24101726
    [Abstract] [Full Text] [Related]

  • 33. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL, Ren SN, Cao H, Tian XF.
    IUBMB Life; 2017 Oct 15; 69(10):795-801. PubMed ID: 28861931
    [Abstract] [Full Text] [Related]

  • 34. Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway.
    Zhu K, Peng Y, Hu J, Zhan H, Yang L, Gao Q, Jia H, Luo R, Dai Z, Tang Z, Fan J, Zhou J.
    Carcinogenesis; 2020 Apr 22; 41(2):130-138. PubMed ID: 31498866
    [Abstract] [Full Text] [Related]

  • 35. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
    Mei L, Chen Y, Wang Z, Wang J, Wan J, Yu C, Liu X, Li W.
    Br J Pharmacol; 2015 May 22; 172(9):2232-45. PubMed ID: 25521075
    [Abstract] [Full Text] [Related]

  • 36. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
    Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang C, Xie S, Chen C, Hu L, Xu S, Liang T.
    Carcinogenesis; 2013 May 22; 34(5):962-73. PubMed ID: 23358852
    [Abstract] [Full Text] [Related]

  • 37. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 38. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
    Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, Qiu SJ, Dai Z, Fan J.
    Autophagy; 2013 Dec 28; 9(12):2056-68. PubMed ID: 24157892
    [Abstract] [Full Text] [Related]

  • 39. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Shen L, Gu P, Qiu C, Ding WT, Zhang L, Cao WY, Li ZY, Yan B, Sun X.
    Ann Hepatol; 2022 Dec 28; 27(3):100680. PubMed ID: 35108614
    [Abstract] [Full Text] [Related]

  • 40. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
    Qin CD, Ma DN, Ren ZG, Zhu XD, Wang CH, Wang YC, Ye BG, Cao MQ, Gao DM, Tang ZY.
    Oncol Rep; 2017 Mar 28; 37(3):1725-1735. PubMed ID: 28112375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.